Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer
NCT00588003
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
anastrozole
OTHER:
Placebo
Sponsor
Memorial Sloan Kettering Cancer Center